Single answer
Is Anika Therapeutics Inc (ANIK) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
Anika Therapeutics Inc a joint preservation company creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis OA pain management regenerative solutions soft tissue repair and bone preserving joint technologies in the United States Europe and internationally The company develops manufactures and commercializes products based on hyaluronic acid HA technology platform Its OA pain management product family consists of Monovisc Orthovisc Cingal and Hyvisc that are indicated to provide pain relief from osteoarthritis conditions and joint preservation and restoration product family comprise a portfolio of approximately 150 bone preserving joint technology products a line of sports medicine soft tissue repair solutions and orthopedic regenerative solutions products The companys nonorthopedic product family include HAbased products for nonorthopedic applications including adhesion barrier products advanced wound care products ophthalmic products and ear nose and throat products Anika Therapeutics Inc was founded in 1983 and is headquartered in Bedford Massachusetts
Website: https://www.anikatherapeutics.com
Rates and inflation backdrop
US inflation for September 2025 was 0.31%. Over the last 12 months, inflation is 3.02%. The 10-year yield is 4.12 and is down -0.1000 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.12. Cash flow to debt ratio: 0.36. Net profit margin: -29.29%. Inflation risk score: high (0.70/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
Yes, the average daily trading liquidity for Anika Therapeutics Inc is $1.2M. You should therefore be able to get in and out of your positions relatively fast.
10-year return check
On Anika Therapeutics Inc, 2015-12-31 had a stock price of $38.16. If you invested back then, your return now would be a loss of $28.61 per share or 74.97%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.